BIOGEN INC. (BIIB) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2007: $284.11M2008: $275.95M2009: $165.65M2010: $173.06M2011: $208.02M2012: $254.55M2013: $246.30M2014: $287.80M2015: $643.00M2016: $616.10M2017: $867.40M2018: $770.60M2019: $514.50M2020: $424.80M2021: $258.10M2022: $240.30M2023: $277.00M2024: $153.70M2025: $153.80M$153.80M
2007Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$153.80M+0.1%
2024$153.70M-44.5%
2023$277.00M+15.3%
2022$240.30M-6.9%
2021$258.10M-39.2%
2020$424.80M-17.4%
2019$514.50M-33.2%
2018$770.60M-11.2%
2017$867.40M+40.8%
2016$616.10M-4.2%
2015$643.00M+123.4%
2014$287.80M+16.8%
2013$246.30M-3.2%
2012$254.55M+22.4%
2011$208.02M+20.2%
2010$173.06M+4.5%
2009$165.65M-40.0%
2008$275.95M-2.9%
2007$284.11M